The company securely gathers, stores, and analyzes data from many users to build neurocognitive profiles of individuals and populations, helping clinical professionals develop the next generation of treatments for neurological disorders and therapies. BrainWaveBank's approach is easy to scale and distribute, with offices in Northern Ireland and Ireland. Cumulus Neuroscience, on the other hand, has developed a next-generation integrated physiological and digital biomarker platform that provides critical data and insights for faster, more effective CNS drug delivery in clinical trials, addressing the significant unmet need for faster, more robust, and cost-effective execution and evaluation of clinical trials in neuroscience.